Acute megakaryoblastic leukemia.
Gassmann W, Löffler H.
Leuk Lymphoma. 1995;18 Suppl 1:69-73. doi: 10.3109/10428199509075307.
Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations.
Lopez CK, Malinge S, Gaudry M, Bernard OA, Mercher T.
Trends Cancer. 2017 Sep;3(9):631-642. doi: 10.1016/j.trecan.2017.07.003. Epub 2017 Aug 18.
Acute megakaryoblastic leukemia mimicking a disseminated tumor.
Lam SYS, Ha SY, So JCC, Cheuk DKL, Chow TTW.
Pediatr Blood Cancer. 2022 Apr;69(4):e29495. doi: 10.1002/pbc.29495. Epub 2021 Nov 29.
Acute megakaryoblastic leukemia.
Rashidi A, Fisher SI.
Blood. 2013 Oct 10;122(15):2537. doi: 10.1182/blood-2013-05-503581.
Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK.
Pediatr Blood Cancer. 2007 Dec;49(7 Suppl):1066-9. doi: 10.1002/pbc.21353.
Therapy-related acute megakaryoblastic leukemia with severe myelofibrosis.
Yoshino H, Gemma Y, Miyazawa N, Bessho F, Yan K.
Pediatr Int. 2022 Jan;64(1):e14842. doi: 10.1111/ped.14842.
Acute Megakaryocytic Leukemia.
McNulty M, Crispino JD.
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034884. doi: 10.1101/cshperspect.a034884.
Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia.
Mukherjee S, Ibrahimi S, John S, Adnan MM, Scordino T, Khalil MO, Cherry M.
Ann Hematol. 2017 Sep;96(9):1435-1439. doi: 10.1007/s00277-017-3037-3. Epub 2017 Jun 3.
CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M, Lebert-Ghali CÉ, Fournier M, Capdevielle C, Garfinkle EAR, Obermayer A, Cotton A, Boulay K, Sawchyn C, St-Amand S, Nguyen KH, Assaf B, Mercier FE, Delisle JS, Drobetsky EA, Hulea L, Shaw TI, Zuber J, Gruber TA, Melichar HJ, Mallette FA.
Cell Rep. 2023 Sep 26;42(9):113084. doi: 10.1016/j.celrep.2023.113084. Epub 2023 Sep 15.
The biology of pediatric acute megakaryoblastic leukemia.
Gruber TA, Downing JR.
Blood. 2015 Aug 20;126(8):943-9. doi: 10.1182/blood-2015-05-567859. Epub 2015 Jul 17.
